股票 › EW
爱德华生命科学 EW
美股市值排名 #376
$102.14 +$1.32 (+1.31%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $102.14 0.00%
开盘$99.00
昨收$100.82
当日区间$98.50 – $102.19
成交量5.11M
市值$58.73B
市盈率（TTM）57.7
股息率–
股权结构与仓位
谁在持有、谁在做空，以及大资金的流向
机构持股比例93.4%+0.14 个百分点，较上季度
持仓机构数1,630+6 ，较上季度
内部人近期交易15次买入 / 35次卖出净卖出
空头持仓比例1.62% 占流通股回补天数 2.5 · 截至 15 Oct 2026
卖空成交量占比15.3%近5日成交量平均占比
卖空成交量占当日成交量比例
大单净流入，近20个交易日
大单买入减卖出的净额（美元）。该窗口期内：+$11.23M（12个净流入日，8个净流出日）。
按单量净流入，近20个交易日
超大单/大单近似机构级别交易；中单/小单近似散户级别交易。各档买入减卖出净额，按窗口期累计。
已披露的前五大股东合计持有29.8%的流通股。
最大股东
按投资者类型
过去6次双周报告中（31 Jul 2026至15 Oct 2026），空头持仓占流通股比例已从1.74%降至1.62%。
近期机构持仓变动
| 股东 | 类型 | 期间 | 持股变动 | 新持股比例 |
|---|---|---|---|---|
| Assenagon Asset Management S.A. | Mutual Fund | 2026/Q3 | +906,345 | 0.5% |
| Aristotle Capital Management, LLC | Mutual Fund | 2026/Q3 | +8,665,712 | 1.5% |
| BlackRock | Mutual Fund | 2026/Q3 | +6,198,500 | 10.2% |
| AllianceBernstein | Mutual Fund | 2026/Q3 | +5,193,061 | 1.5% |
| Arrowstreet Capital, Limited Partnership | Mutual Fund | 2026/Q3 | +3,786,485 | 1.0% |
| Citadel Advisors LLC | Hedge Fund | 2026/Q3 | +3,478,894 | 0.7% |
| Holocene Advisors, LP | Hedge Fund | 2026/Q3 | +2,401,186 | 0.5% |
| Geode Capital Management, LLC | Mutual Fund | 2026/Q3 | +2,303,474 | 2.7% |
| Managed Account Advisors LLC | Mutual Fund | 2026/Q3 | +2,267,822 | 0.5% |
| Millennium Management LLC | Hedge Fund | 2026/Q3 | +1,517,420 | 0.6% |
| Artisan Partners Limited Partnership | Mutual Fund | 2026/Q3 | +1,424,559 | 1.1% |
| J.P. Morgan Asset Management, Inc. | Mutual Fund | 2026/Q3 | +1,340,501 | 3.4% |
| Polar Capital Holdings Plc | Mutual Fund | 2026/Q3 | +1,104,860 | 0.2% |
| ABN AMRO Bank N.V. | Public Company | 2026/Q3 | +798,696 | 0.2% |
| Baillie Gifford | Mutual Fund | 2026/Q3 | +768,737 | 0.2% |
按报告期列出的机构买卖动态，变动幅度从大到小排列。
内部人交易
| 日期 | 内部人 | 职位 | 交易类型 | 股数 | 价格 | 交易后持股 |
|---|---|---|---|---|---|---|
| 7 Oct 2026 | Daniel Lippis | Corporate Vice President of JAPAC (Japan, Greater China & Asia Pacific) | Derivative Exercise and Sale | -619 | $85.65 | 12,415 |
| 13 Sep 2026 | Wayne Markowitz | GM & Senior VP of Surgical Structural Heart | Sale to Issuer | -923 | $86.77 | 3,360 |
| 12 Sep 2026 | Andrew Dahl | Principal Accounting Officer, Senior VP & Corporate Controller | Sale to Issuer | -253 | $84.37 | 2,489 |
| 10 Sep 2026 | Daveen Chopra | Corporate Vice President of Transcatheter Mitral & Tricuspid Therapies | Sale to Issuer | -398 | $86.77 | 19,829 |
| 10 Sep 2026 | Daniel Lippis | Corporate Vice President of JAPAC (Japan, Greater China & Asia Pacific) | Derivative Exercise and Sale | -619 | $87.51 | 12,415 |
| 30 Aug 2026 | Andrew Dahl | Principal Accounting Officer, Senior VP & Corporate Controller | Open Market Disposition | -544 | $91.06 | 2,012 |
| 27 Aug 2026 | Annette Bruls | Corporate Vice President of EMEA, Canada, & Latin America | Open Market Disposition | -2,644 | $89.98 | 1,697 |
| 25 Aug 2026 | Daveen Chopra | Corporate Vice President of Transcatheter Mitral & Tricuspid Therapies | Derivative Exercise and Sale | -31,800 | $91.76 | 19,425 |
| 25 Aug 2026 | Wayne Markowitz | GM & Senior VP of Surgical Structural Heart | Open Market Disposition | -1,240 | $91.47 | 865 |
| 10 Aug 2026 | Daniel Lippis | Corporate Vice President of JAPAC (Japan, Greater China & Asia Pacific) | Derivative Exercise and Sale | -619 | $92.03 | 12,415 |
| 29 Jul 2026 | Scott Ullem | Former Corporate VP & CFO | Intent to Sell (Form 144) | -50,000 | $92.50 | – |
| 29 Jul 2026 | Wayne Markowitz | GM & Senior VP of Surgical Structural Heart | Open Market Disposition | -146 | $86.03 | 2,105 |
| 27 Jul 2026 | Wayne Markowitz | GM & Senior VP of Surgical Structural Heart | Derivative Exercise and Sale | -9,628 | $85.06 | 2,251 |
| 26 Jul 2026 | Bernard Zovighian | Chief Executive Officer | Other Acquisition | +319 | – | 111,494 |
| 26 Jul 2026 | Bernard Zovighian | Chief Executive Officer | Other Disposition | -319 | – | 111,494 |
| 26 Jul 2026 | Bernard Zovighian | Chief Executive Officer | Open Market Disposition | -2,920 | $83.93 | 111,494 |
| 10 Jul 2026 | Annette Bruls | Corporate Vice President of EMEA, Canada, & Latin America | Sale to Issuer | -109 | $92.21 | 4,341 |
| 9 Jul 2026 | Daniel Lippis | Corporate Vice President of JAPAC (Japan, Greater China & Asia Pacific) | Derivative Exercise and Sale | -619 | $91.70 | 12,415 |
| 8 Jul 2026 | Theodora Mistras | Corporate VP & CFO | Other Acquisition | +99,920 | – | 99,920 |
| 8 Jul 2026 | Theodora Mistras | Corporate VP & CFO | Other Derivative Acquisition | +12,325 | – | 12,325 |
数据来自Form 4/Form 144申报文件。负数为减持（出售、赠予或代扣税款股份），正数为增持。
空头持仓（按报告期）
| 报告日期 | 空头股数 | 占流通股比例 | 回补天数 |
|---|---|---|---|
| 15 Oct 2026 | 9,333,399 | 1.6% | 2.5 |
| 30 Sep 2026 | 9,538,735 | 1.7% | 2.5 |
| 15 Sep 2026 | 9,088,401 | 1.6% | 3.2 |
| 31 Aug 2026 | 9,022,064 | 1.6% | 3.2 |
| 14 Aug 2026 | 10,241,231 | 1.8% | 3.1 |
| 31 Jul 2026 | 10,043,721 | 1.7% | 1.8 |
暂无评论——快来第一个聊聊 EW。
登录后参与讨论。